Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors

QR Code

Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors

INTRODUCTION. Marburg and Ebola viruses cause severe haemorrhagic fever in humans and primates. Currently, there are no licensed prophylactic vaccines that can simultaneously prevent the spread or reduce the severity of both diseases caused by these filoviruses. The development of effective prophyla...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. A. Ozharovskaia, O. V. Zubkova, O. Popova, A. V. Kovyrshina, P. P. Goldovskaya, I. V. Vavilova, I. V. Dolzhikova, E. I. Ermolova, M. S. Kunda, N. N. Ryzhova, O. L. Voronina, D. N. Shcherbinin, D. V. Shcheblyakov, D. Y. Logunov, A. L. Gintsburg
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-10-01
Series:	Биопрепараты: Профилактика, диагностика, лечение
Subjects:	immunogenicity glycoprotein gene variants ebola virus marburg virus human adenovirus type 5 recombinant adenoviral vectors ebola virus disease marburg virus disease humoral immune response
Online Access:	https://www.biopreparations.ru/jour/article/view/576
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development of the Multiplex Real-Time PCR for Marburg, Ebola, and Lassa Viruses Identification
by: A. O. Sementsova, et al.
Published: (2011-06-01)

Obtaining and Immunologic Characterization of Filoviruses Recombinant Proteins VP40 and NP
by: A. V. Ivanova, et al.
Published: (2010-08-01)

MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS OF FILOVIRUSES: IMMUNOCHEMICAL PROPERTIES AND EVALUATION OF THEIR EFFICIENCY FOR IMMUNE DIAGNOSTICS OF MARBURG AND EBOLA VIRUSES
by: E. I. Kazachinskaia, et al.
Published: (2014-07-01)

Prospects For the Use of Loop Isothermal Amplification in the Diagnosis of Particularly Dangerous Infectious Diseases Caused by the Viruses of the Pathogenicity Group I
by: M. Yu. Kartashov, et al.
Published: (2020-07-01)

Preparation of Class Y Immunoglobulins that Neutralize the Marburg Virus
by: O. A. Polezhaeva, et al.
Published: (2021-02-01)

Emergence of deadly viral haemorrhagic fever disease outbreaks in West Africa
by: Widaliz Vega-Rodriguez, et al.
Published: (2023-12-01)

Experimental Vaccines for Prevention of Marburg Hemorrhagic Fever and Animal Models for Studying Pathogenesis
by: N. V. Volkova, et al.
Published: (2018-10-01)

Marburg Fever in Equatorial Guinea, Tanzania, and Rwanda: Global Crisis in Public Health Service or Standard Situation?
by: M. V. Supotnitskiy, et al.
Published: (2025-02-01)

Marburg Virus Disease: Pathophysiology, Diagnostic Challenges, and Global Health Preparedness Strategies
by: Delfin Lovelina Francis, et al.
Published: (2025-06-01)

Transcriptional profiling of immune responses in NHPs after low-dose, VSV-based vaccination against Marburg virus
by: Cecilia A. Prator, et al.
Published: (2023-12-01)

Serological and Laboratory Profile of Individuals with Latent form of Ebola Virus Disease in an Endemic region of West Africa
by: O. V. Maltsev, et al.
Published: (2025-07-01)

Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents
by: Jinhong Chang, et al.
Published: (2013-01-01)

Neuro-ophthalmic manifestations in a cohort of Ebola virus disease survivors from Sierra Leone: Ocular implications during convalescence
by: Nam V. Nguyen, et al.
Published: (2025-08-01)

The results of the detection of specific IgG antibodies to Ebola virus (Filoviridae: <i>Orthoebolavirus</i>) in residents of the Republic of Guinea after the end of the epidemic
by: Ekaterina V. Naidenova, et al.
Published: (2025-04-01)

Immunogenic and Protective Features of the Recombinant Vaccinia Virus Strain Expressing Cassette of Genes of Marburg Virus Structural Proteins
by: A. V. Semenova, et al.
Published: (2022-01-01)

Obtaining Recombinant Antigens for the Development of Serological Diagnosis of Marburg Fever
by: N. V. Volkova, et al.
Published: (2021-02-01)

Thirteen-Year Sequelae of Marburg Virus Disease Survival: Persistent Cardiometabolic, Immunometabolic, and Haematological Alterations in the Absence of Psychological Morbidity
by: Jennifer Serwanga, et al.
Published: (2025-07-01)

N6-methyladenosine is required for efficient RNA synthesis of Ebola virus and other haemorrhagic fever viruses
by: Lisa Wendt, et al.
Published: (2023-12-01)

Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination
by: Markus H. Kainulainen, et al.
Published: (2023-12-01)

Unveiling Palmitoyl Thymidine Derivatives as Antimicrobial/Antiviral Inhibitors: Synthesis, Molecular Docking, Dynamic Simulations, ADMET, and Assessment of Protein–Ligand Interactions
by: Sarkar M. A. Kawsar, et al.
Published: (2025-05-01)

Disease caused by the Ebola virus: from theory to practice
by: K. V. Zhdanov, et al.
Published: (2015-04-01)

Scientific-Methodological Approach to the Epidemiological Analysis and Laboratory Diagnostics of the Diseases Caused by Marburg and Ebola Viruses
by: A. M. Titenko, et al.
Published: (2012-06-01)

Experience of Application of the ELISA Method for Detection of Antibodies to Ebola Virus during the SAET Team Work in the Republic of Guinea
by: S. A. P’yankov, et al.
Published: (2016-09-01)

From Bat to Worse: The Pivotal Role of Bats for Viral Zoonosis
by: Harald Brüssow
Published: (2025-07-01)

Study of the protective properties of immunodominant proteins of orthopoxviruses in various methods of immunization
by: Denis I. Zrelkin, et al.
Published: (2025-03-01)

Highly Effective xMAP Multiplex Assay for the Detection and Identification of Hemorrhagic Fever Agents, Including Ebola Virus
by: V. A. Ternovoy, et al.
Published: (2015-09-01)

Epidemiology and Genetic Characterization of Distinct Ebola Sudan Outbreaks in Uganda
by: Francesco Branda, et al.
Published: (2025-05-01)

Contribution of the Russian Federation to strengthening of epidemiological surveillance Over Dangerous Infectious Diseases in the Republic of Guinea
by: A. Yu. Popova, et al.
Published: (2019-10-01)

The Molecular Genetic Peculiarities of Genomic Structure of Members of the <i>Ebolavirus</i> Genus
by: A. A. Petrov, et al.
Published: (2015-09-01)

Improvement of Diagnostic System in a Real-Time RT-PCR “AmpliSens EBOV (ZAIRE)-FL” Format for Zaire ebolavirus RNA Detection
by: V. G. Dedkov, et al.
Published: (2015-09-01)

Comparison of the Efficacy of Different Schemes for Using Recombinant Vector Vaccines against Ebola Fever, Based on Vaccinia Virus, MVA Strain
by: L. F. Stovba, et al.
Published: (2024-01-01)

10th Ebola Outbreak in the Democratic Republic of the Congo Declared Over; Vigilance against Flare-Ups and Support for Survivors Must Continue
by: article Editorial
Published: (2020-07-01)

Development of a Novel, Highly Sensitive System for Evaluating Ebola Virus Particle Formation
by: Wakako Furuyama, et al.
Published: (2025-07-01)

Epidemiological Peculiarities and Clinical Features of Ebola Virus Disease in the Republic of Guinea
by: V. V. Maleev, et al.
Published: (2015-09-01)

Filovirus infections: science and innovation
by: L. N. Aftaeva, et al.
Published: (2025-01-01)

The preparations for war expeditions to Lithuania and Samogitia according to the Chronicle by Wigand of Marburg
by: Antoni Romuald Chodyński
Published: (2002-01-01)

Monoclonal Antibodies and Recombinant Proteins for Immune-Diagnostics of Ebola Virus Disease
by: E. I. Kazachinskaya, et al.
Published: (2015-09-01)

Russia – Guinea: Historical Aspects of Scientific Cooperation in the Fight against Dangerous Infectious Diseases
by: A. Yu. Popova, et al.
Published: (2024-10-01)

Clinical and Occupational Predictors of Mortality in Ebola Virus Disease: A Commentary from the Democratic Republic of Congo (2018–2020)
by: Jean Paul Muambangu Milambo, et al.
Published: (2025-06-01)

Management and Performance of Diagnostic Investigations on the Platform of the Specialized Anti-Epidemic Team Mobile Complex During EVD Epidemics in 2014 in the Republic of Guinea
by: A. Yu. Popova, et al.
Published: (2014-12-01)